Most Read Articles
Roshini Claire Anthony, 02 Dec 2020

People with HIV (PWH) who are hospitalized due to COVID-19 may have an increased mortality risk, according to a study from the UK.

Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 07 Oct 2020

In patients with severe eosinophilic asthma, cessation of mepolizumab may lead to increased exacerbations and reductions in asthma control, according to results of the COMET* trial.

Antimicrobial Stewardship in Managing URTIs

22 Jul 2020
Upper respiratory tract infections (URTIs), in general, are caused by viral pathogens and do not require antibiotics; however, several cases have ended up with inappropriate antibiotic prescription. This may lead to the development of antimicrobial resistance (AMR), which in turn can result in increased risk of the spread of infection, increased cost of treatment and even increased number of fatalities due to antibiotic-resistant infections.

Professor Roman Kozlov, the rector of Smolensk State Medical University and Chief Specialist of the Ministry of Health of the Russian Federation on Clinical Microbiology and Antimicrobial Resistance, discusses in this webcast the global problem of antibiotic overprescription in URTI and its implications to health. He also discusses the correct approach to URTI management.
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 02 Dec 2020

People with HIV (PWH) who are hospitalized due to COVID-19 may have an increased mortality risk, according to a study from the UK.

Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 07 Oct 2020

In patients with severe eosinophilic asthma, cessation of mepolizumab may lead to increased exacerbations and reductions in asthma control, according to results of the COMET* trial.